Revelation Biosciences's total assets for Q1 2026 were $15.04M, an increase of 29.88% from the previous quarter. REVB total liabilities were $2.06M for the fiscal quarter, a -24.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.